Carbamazepine
1
Reactions 383 - 11 Jan 1992 Carbamazepine Neuroleptic malignant syndrome: case report Clear symptoms of neuroleptic malignant syndrome developed in a 57-year-old man after 21 days’ carbamazepine therapy. Carbemazepine therapy had been given because of psychosis refractory to electroconvulsive therapy. Neuroleptic malignant syndrome had occurred previously during neuroleptic therapy. Both episodes were controlled after drug withdrawal. The resolution of symptoms upon carbamazepine withdrawal ’... suggest carbamazepine as their cause’ O’Griofa FM, et al. Neuroleptic malignant syndrome associated with carbamazepine. Southern Medical Journal 84: 1378-1380, Nov 1991 - USA 800110204 1 Reactions 11 Jan 1992 No. 383 0114-9954/10/0383-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
Transcript of Carbamazepine
Reactions 383 - 11 Jan 1992
Carbamazepine
Neuroleptic malignant syndrome: case reportClear symptoms of neuroleptic malignant syndrome
developed in a 57-year-old man after 21 days’ carbamazepinetherapy. Carbemazepine therapy had been given because ofpsychosis refractory to electroconvulsive therapy. Neurolepticmalignant syndrome had occurred previously duringneuroleptic therapy. Both episodes were controlled after drugwithdrawal.
The resolution of symptoms upon carbamazepinewithdrawal ’... suggest carbamazepine as their cause’O’Griofa FM, et al. Neuroleptic malignant syndrome associated withcarbamazepine. Southern Medical Journal 84: 1378-1380, Nov 1991 -USA 800110204
1
Reactions 11 Jan 1992 No. 3830114-9954/10/0383-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
